Hong Kong-listed biopharmaceutical stocks rose amid volatility, with Innovent Biologics (09969.HK) surging over 4%, and other stocks such as Zai Lab (09688.HK), WuXi AppTec (02359.HK), WuXi Biologics (02269.HK), and Henlius Biotech (02696.HK) following suit.